Zobrazeno 1 - 6
of 6
pro vyhledávání: '"COVID-19 Working Group in Perú"'
Autor:
Manolo Fernández Díaz, Katherine Calderón, Aldo Rojas-Neyra, Vikram N. Vakharia, Ricardo Choque-Guevara, Angela Montalvan-Avalos, Astrid Poma-Acevedo, Dora Rios-Matos, Andres Agurto-Arteaga, Maria de Grecia Cauti-Mendoza, Norma Perez-Martinez, Gisela Isasi-Rivas, Luis Tataje-Lavanda, Yacory Sernaque-Aguilar, Freddy Ygnacio, Manuel Criollo-Orozco, Edison Huaccachi-Gonzalez, Elmer Delgado-Ccancce, Doris Villanueva-Pérez, Ricardo Montesinos-Millán, Kristel Gutiérrez-Manchay, Katherinne Pauyac-Antezana, Ingrid Ramirez-Ortiz, Stefany Quiñones-Garcia, Yudith Cauna-Orocollo, Katherine Vallejos-Sánchez, Angela Rios-Angulo, Dennis Núñez-Fernández, Mario I. Salguedo-Bohorquez, Julio Ticona, Manolo Fernández-Sánchez, Eliana Icochea, Luis A. Guevara-Sarmiento, Mirko Zimic, COVID-19 Working Group in Perú
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-18 (2022)
Abstract The coronavirus disease-19 (COVID-19) pandemic has already claimed millions of lives and remains one of the major catastrophes in the recorded history. While mitigation and control strategies provide short term solutions, vaccines play criti
Externí odkaz:
https://doaj.org/article/696e9de1515149608bd5186f685f0c3b
Autor:
Gabriel Jiménez-Avalos, A. Paula Vargas-Ruiz, Nicolás E. Delgado-Pease, Gustavo E. Olivos-Ramirez, Patricia Sheen, Manolo Fernández-Díaz, Miguel Quiliano, Mirko Zimic, COVID-19 Working Group in Perú
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-19 (2021)
Abstract SARS-CoV-2 main protease is a common target for inhibition assays due to its high conservation among coronaviruses. Since flavonoids show antiviral activity, several in silico works have proposed them as potential SARS-CoV-2 main protease in
Externí odkaz:
https://doaj.org/article/70a95756c88d494c934f01fa64c2c631
Autor:
Andres Agurto-Arteaga, Astrid Poma-Acevedo, Dora Rios-Matos, Ricardo Choque-Guevara, Ricardo Montesinos-Millán, Ángela Montalván, Gisela Isasi-Rivas, Yudith Cauna-Orocollo, María de Grecia Cauti-Mendoza, Norma Pérez-Martínez, Kristel Gutierrez-Manchay, Ingrid Ramirez-Ortiz, Dennis Núñez-Fernández, Mario I. Salguedo-Bohorquez, Stefany Quiñones-Garcia, Manolo Fernández Díaz, Luis A. Guevara Sarmiento, Mirko Zimic, COVID-19 Working Group in Perú, Ricardo Antiparra, Manuel Ardiles-Reyes, Katherine Calderón, Maria de Grecia Cauti-Mendoza, Naer Chipana-Flores, Xiomara Chunga-Girón, Manuel Criollo-Orozco, Lewis De La Cruz, Nicolás E. Delgado-Pease, Elmer Delgado-Ccancce, Christian Elugo-Guevara, Manolo Fernández-Díaz, Manolo Fernández-Sánchez, Luis Guevara-Sarmiento, Kristel Gutiérrez, Oscar Heredia-Almeyda, Edison Huaccachi-Gonzalez, Pedro Huerta-Roque, Eliana Icochea, Gabriel Jiménez-Avalos, Romina A. Juscamaita-Bartra, Abraham Licla-Inca, Angela Montalván, Adiana Ochoa-Ortiz, Gustavo E. Olivos-Ramirez, Erika Páucar-Montoro, Kathy Pauyac, Jose L. Perez-Martinez, Norma Pérez-M, Daniel Ramos-Sono, Angela A. Rios-Angulo, Aldo Rojas-Neyra, Yomara K. Romero, Yacory Sernaque-Aguilar, Patricia Sheen-Cortavarrı́a, Luis F. Soto, Luis Tataje-Lavanda, Julio Ticona, Katherine Vallejos-Sánchez, A. Paula Vargas-Ruiz, Doris Villanueva-Pérez, Freddy Ygnacio-Aguirre, Mirko Zimic-Peralta
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Within the framework of the current COVID-19 pandemic, there is a race against time to find therapies for the outbreak to be controlled. Since vaccines are still tedious to develop and partially available for low-income countries, passive immunity ba
Externí odkaz:
https://doaj.org/article/b87b2f7e669c4f6f8d6f5e8c60f85c40
Autor:
Ricardo Choque-Guevara, Astrid Poma-Acevedo, Ricardo Montesinos-Millán, Dora Rios-Matos, Kristel Gutiérrez-Manchay, Angela Montalvan-Avalos, Stefany Quiñones-Garcia, Maria de Grecia Cauti-Mendoza, Andres Agurto-Arteaga, Ingrid Ramirez-Ortiz, Manuel Criollo-Orozco, Edison Huaccachi-Gonzales, Yomara K Romero, Norma Perez-Martinez, Gisela Isasi-Rivas, Yacory Sernaque-Aguilar, Doris Villanueva-Pérez, Freddy Ygnacio, Katherine Vallejos-Sánchez, Manolo Fernández-Sánchez, Luis A Guevara-Sarmiento, Manolo Fernández-Díaz, Mirko Zimic, COVID-19 Working Group in Perú
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0269823 (2022)
COVID-19 pandemic has accelerated the development of vaccines against its etiologic agent, SARS-CoV-2. However, the emergence of new variants of the virus lead to the generation of new alternatives to improve the current sub-unit vaccines in developm
Externí odkaz:
https://doaj.org/article/b51b31835bb7495ea4f9074b8b477e35
Autor:
Jiménez-Avalos, Gabriel, Vargas-Ruiz, A. Paula, Delgado-Pease, Nicolás E., Olivos-Ramirez, Gustavo E., Sheen, Patricia, Fernández-Díaz, Manolo, Quiliano, Miguel, Zimic, Mirko, COVID-19 Working Group in Perú, Agurto-Arteaga, Andres, Antiparra, Ricardo, Ardiles-Reyes, Manuel, Calderon, Katherine, Cauna-Orocollo, Yudith, de Grecia Cauti-Mendoza, Maria, Chipana-Flores, Naer, Choque-Guevara, Ricardo, Chunga-Girón, Xiomara, Criollo-Orozco, Manuel, De La Cruz, Lewis
Publikováno v:
Scientific Reports; 7/29/2021, Vol. 11 Issue 1, p1-19, 19p
Autor:
Jiménez-Avalos, Gabriel1 gabriel.jimenez.a@upch.pe, Vargas-Ruiz, A. Paula1, Delgado-Pease, Nicolás E.1, Olivos-Ramirez, Gustavo E.1, Sheen, Patricia1, Fernández-Díaz, Manolo2, Quiliano, Miguel3, Zimic, Mirko1,2 mirko.zimic@upch.pe, COVID-19 Working Group in Perú, Agurto-Arteaga, Andres2, Antiparra, Ricardo1, Ardiles-Reyes, Manuel1, Calderon, Katherine2, Cauna-Orocollo, Yudith1, de Grecia Cauti-Mendoza, Maria2, Chipana-Flores, Naer2, Choque-Guevara, Ricardo2, Chunga-Girón, Xiomara1, Criollo-Orozco, Manuel2, De La Cruz, Lewis1
Publikováno v:
Scientific Reports. 7/29/2021, Vol. 11 Issue 1, p1-19. 19p.